ALIMTA 500 mg

Recall | Medicines | 05/04/2012

The distributor has informed its supplied customers in a letter dated April 5, 2012, that the sterility of the batches listed above can no longer be guaranteed and therefore a recall is being carried out as a precautionary measure.

Name of the medicinal product ALIMTA 500 mg Pulver zur Herstellung eines Konzentrates zur Herstellung einer Infusionslösung
Marketing authorisation number(s) EU/1/04/290/001
Marketing authorisation holder Eli Lilly Nederland BV

Vertrieb und Durchführung Rückruf:
Axeleris Pharma GmbH
Batch number(s) A931727F (207606) und A931727F (206813)
Classification of the recall1
BASG reference number INS-640.001-0412
Email

Further inquiry note